The Total revenue for the quarter ended March 2024 of  Rs. 119.73 millions remain, more or less, the same.The Net Loss for the quarter ended March 2024 is Rs. -58.48 millions as compared to Net Loss of Rs. -69.39 millions of corresponding quarter ended March 2023 Operating profit Margin for the quarter ended March 2024 improved to -29.04% as compared to -44.31% of corresponding quarter ended March 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 119.73 114.61 4.47 504.22 521.34 -3.28 504.22 521.34 -3.28
Other Income 2.10 1.93 8.81 4.51 6.20 -27.26 4.51 6.20 -27.26
PBIDT -29.04 -44.31 -34.46 -82.72 -151.59 -45.43 -82.72 -151.59 -45.43
Interest 12.72 10.28 23.74 46.89 29.73 57.72 46.89 29.73 57.72
PBDT -41.76 -54.59 -23.50 -129.61 -181.32 -28.52 -129.61 -181.32 -28.52
Depreciation 16.72 14.80 12.97 67.66 65.59 3.16 67.66 65.59 3.16
PBT -58.48 -69.39 -15.72 -197.27 -246.91 -20.10 -197.27 -246.91 -20.10
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -58.48 -69.39 -15.72 -197.27 -246.91 -20.10 -197.27 -246.91 -20.10
Equity 215.61 215.61 0.00 215.61 215.61 0.00 215.61 215.61 0.00
PBIDTM(%) -24.25 -38.66 -37.26 -16.41 -29.08 -43.58 -16.41 -29.08 -43.58

Krebs Biochem.&Inds Share Price

55.11 0.00 (0.00%)
11-Mar-2026 13:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1830.60
Dr. Reddys Lab 1326.30
Cipla 1335.00
Zydus Lifesciences 927.95
Lupin 2364.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×